Skip to content
naulon
Not checkedNot checked for notices yet.

Massive hypertriglyceridemia associated with paclitaxel; a case report

Anojian Koneshamoorthy, Danielle Hulse, Chia Yuen Chong and 3 more

Gynecologic Oncology Reports · 2022

doi:10.1016/j.gore.2022.101030 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

This report describes a patient who developed massive hypertriglyceridemia (12,488 mg/dL or 141 mmol/L) during paclitaxel and carboplatin adjuvant chemotherapy for high grade serous fallopian tube carcinoma. Paclitaxel was thought to be the causative agent and she had normal triglyceride levels following a change to carboplatin and gemcitabine. To our knowledge, this is the highest reported triglyceride level associated with paclitaxel. Measurement of serum lipids should be considered in individuals receiving taxane chemotherapy, especially in those with type 2 diabetes mellitus or a history of dyslipidemia.

Abstract licence: CC BY-NC

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.